GSK

(Biotechnology, Medicine and Health)

Introduction

GSK is a company focused on health care. It has three world leading business that research, develop and produce medicines, vaccines and products for daily health care.

It operates in 150 countries forming a global team of 100,000 people, of which more than 10,000 are researchers.

 


The information contained in this business data sheep has been provided by the company and the University of Valencia Science Park Foundation (FPCUV) is not responsible for its content.

Download Impulse to Business Development Programme (PIDE)'s file
GSK

Technology offer

Technical Specifications
  • Pharmaceutical Division: Development and production of drugs for the treatment of a large number of acute and chronic diseases. Leading company in the areas of Respiratory and HIV.
  • Rare Diseases: Development of innovative solutions for people affected by these diseases, such as amyloidosis, lysosomal diseases, primary immune deficiencies and pulmonary arterial hypertension.
  • R&D: In 2015 GSK allocated 3.100 million pounds to the research and development of new drugs and 52.6 million euros in Spain.
  • Vaccines: Leaders in vaccines thanks to the development, production and distribution of a wide portfolio of pediatric vaccines for adolescents, adults and travelers.
  • Consumer Healthcare: Development and commercialization of some of the most recognized and best-selling brands in the world for the control of pain, nutrition, and oral, digestive and dermatological health.
  • HIV: Global leadership through the company ViiV Healthcare, a global company specializing in HIV, of which GSK is a majority partner with Pfizer and Shionogi
  • Production: Through our 80 manufacturing plants, we serve clients from 190 countries. In Spain, the company has two production centers: Aranda del Duero (Burgos) and Alcalá de Henares (Madrid).

Contact information

Natalia Galeranatalia.m.galera@gsk.com
https://es.gsk.com/